Ethacrynate Sodium Powder for Injection

31 January 2007

Products Affected - Description

Ethacrynate sodium 50 mg powder for injection (Edecrin sodium, NDC 00006-3620-50), Aton Pharma

Reason for the Shortage

Merck has sold several products to Aton Pharma, a subsidiary of Princeton Pharma. Aton Customer service reports that all the products are available and are shipping to most wholesalers, with the exception of Amerisource Bergen. Aton ships product only to wholesalers; hospitals and pharmacies cannot obtain product via direct orders. For more information about products affected by this divestiture, visit http://www.ashp.org/s_ashp/doc1.asp?CID=998&DID=6804

Estimated Resupply Dates

Aton is working with Amerisource Bergen to finalize purchasing agreements, and cannot estimate when this process may be finalized.

Related Shortages

• Citrate/Phosphate/Dextrose— No Longer Available
• Ethacrynic Acid Tablets— Resolved
• Phosphorous Supplements Oral— Resolved
• Sodium Bicarbonate Tablets— Resolved

Updated

January 31 and January 10, 2007; University of Utah Drug Information Service

Back to Drug Shortage Product Bulletins